Both higher level of (bcr,abl) transcripts and high Hasford risk score are associated with cytogenetic response but absence of molecular remission during first line use of imatinib mesilate(IM): A finding not observed following use among interferon failures.

---

TOPRAK S. K., Dalva K., Mizrak D., Arat M., Ozcan M., GÜRMAN G., ...More

46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 4 - 07 December 2004, vol.104, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 104
• City: California
• Country: United States Of America
• Ankara University Affiliated: Yes